FDA Dismisses List Of “Grandfathered” Ingredients In Pyridoxamine Decision
This article was originally published in The Tan Sheet
Executive Summary
Companies determining whether a substance is a new dietary ingredient cannot rely on industry-developed lists of "grandfathered" ingredients believed to be marketed prior to the Dietary Supplement Health and Education Act, FDA says in response to a citizen petition
You may also be interested in...
Pyridoxamine Debate Continues; CRN Points To Ingredient’s Presence In Food
Pyridoxamine's presence in many common foods makes it exempt from 75-day premarket notification, the Council for Responsible Nutrition maintains in comments supporting the ingredient's status as a dietary supplement
BioStratum, CRN Spar Over Pyridoxamine’s Pre-DSHEA Marketing Status
BioStratum insists there is no evidence supporting the Council for Responsible Nutrition's claim that pyridoxamine was sold as a dietary ingredient before 1994 and says the ingredient should not be considered "grandfathered" under DSHEA
J&J Consumer Sales Slip Even As Recalled Brands, Seasonal Items Reach Stores
J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.